Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: A balancing act between protection and pathology

International Immunopharmacology

Volumn 8, Issue 10, 2008, Pages 1338-1343

  Gollob, Kenneth J ^a   Antonelli, Lis R V ^b   Faria, Daniela R ^a   Keesen, Tatjana S L ^a   Dutra, Walderez O ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cutaneous leishmaniasis; Cytokines; Double negative T cells; NK T cells; T lymphocytes; Th1

Indexed keywords

ANTIMONY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; IMMUNOREGULATION; LEISHMANIA; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; PSYCHODIDAE; SKIN LEISHMANIASIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VACCINE PRODUCTION;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; ARGINASE; FORECASTING; HUMANS; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS;

EID: 50949116462     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.03.016     Document Type: Article

References (42)

1. Herwaldt B.L. Leishmaniasis. Lancet 354 9185 (Oct 2 1999) 1191-1199
2. Coutinho S.G., Pirmez C., and Da-Cruz A.M. Parasitological and immunological follow-up of American tegumentary leishmaniasis patients. Trans R Soc Trop Med Hyg 96 Suppl 1 (Apr 2002) S173-S178
3. de Oliveira-Neto M.P., Mattos M.S., Perez M.A., Da-Cruz A.M., Fernandes O., Moreira J., et al. American tegumentary leishmaniasis (ATL) in Rio de Janeiro State, Brazil: main clinical and epidemiologic characteristics. Int J Dermatol 39 7 (Jul 2000) 506-514
4. Barral A., Pedral-Sampaio D., Grimaldi Junior G., Momen H., McMahon-Pratt D., Ribeiro de Jesus A., et al. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 44 5 (May 1991) 536-546
5. Coffman R.L., Chatelain R., Leal L.M., and Varkila K. Leishmania major infection in mice: a model system for the study of CD4+ T-cell subset differentiation. Res Immunol 142 1 (Jan 1991) 36-40
6. Scott P. T-cell subsets and T-cell antigens in protective immunity against experimental leishmaniasis. Curr Top Microbiol Immunol 155 (1990) 35-52
7. Locksley R.M., Wakil A.E., Corry D.B., Pingel S., Bix M., and Fowell D.J. The development of effector T cell subsets in murine Leishmania major infection. Ciba Found Symp 195 (1995) 110-117 [discussion 7-22]
8. Chatelain R., Mauze S., and Coffman R.L. Experimental Leishmania major infection in mice: role of IL-10. Parasite Immunol 21 4 (Apr 1999) 211-218
9. Belkaid Y., Hoffmann K.F., Mendez S., Kamhawi S., Udey M.C., Wynn T.A., et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 194 10 (Nov 19 2001) 1497-1506
10. Peters N., and Sacks D. Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol Rev 213 (Oct 2006) 159-179
11. Sacks D., and Anderson C. Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice. Immunol Rev 201 (Oct 2004) 225-238
12. Scott P. Development and regulation of cell-mediated immunity in experimental leishmaniasis. Immunol Res 27 2-3 (2003) 489-498
13. Kaye P.M., Svensson M., Ato M., Maroof A., Polley R., Stager S., et al. The immunopathology of experimental visceral leishmaniasis. Immunol Rev 201 (Oct 2004) 239-253
14. Belkaid Y. The role of CD4(+)CD25(+) regulatory T cells in Leishmania infection. Expert Opin Biol Ther 3 6 (Sep 2003) 875-885
15. Scott P. Immunologic memory in cutaneous leishmaniasis. Cell Microbiol 7 12 (Dec 2005) 1707-1713
16. Zaph C., Uzonna J., Beverley S.M., and Scott P. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat Med 10 10 (Oct 2004) 1104-1110
17. Gaze S.T., Dutra W.O., Lessa M., Lessa H., Guimaraes L.H., Jesus A.R., et al. Mucosal leishmaniasis patients display an activated inflammatory T-cell phenotype associated with a nonbalanced monocyte population. Scand J Immunol 63 1 (Jan 2006) 70-78
18. Faria D.R., Gollob K.J., Barbosa Jr. J., Schriefer A., Machado P.R., Lessa H., et al. Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun 73 12 (Dec 2005) 7853-7859
19. Bacellar O., Lessa H., Schriefer A., Machado P., Ribeiro de Jesus A., Dutra W.O., et al. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 70 12 (Dec 2002) 6734-6740
20. Antonelli L.R., Dutra W.O., Almeida R.P., Bacellar O., Carvalho E.M., and Gollob K.J. Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis. Immunol Lett 101 2 (Nov 15 2005) 226-230
21. Bottrel R.L., Dutra W.O., Martins F.A., Gontijo B., Carvalho E., Barral-Netto M., et al. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect Immun 69 5 (May 2001) 3232-3239
22. Antonelli L.R., Dutra W.O., Almeida R.P., Bacellar O., and Gollob K.J. Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation. Clin Exp Immunol 136 2 (May 2004) 341-348
23. Gomes-Silva A., de Cassia Bittar R., Dos Santos Nogueira R., Amato V.S., da Silva Mattos M., Oliveira-Neto M.P., et al. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?. Clin Exp Immunol 149 3 (Sep 2007) 440-444
24. Sornasse T., Larenas P.V., Davis K.A., de Vries J.E., and Yssel H. Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J Exp Med 184 2 (Aug 1 1996) 473-483
25. Anderson C.F., Oukka M., Kuchroo V.J., and Sacks D. CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204 2 (Feb 19 2007) 285-297
26. O'Garra A., and Vieira P. T(H)1 cells control themselves by producing interleukin-10. Nat Rev 7 6 (Jun 2007) 425-428
27. Campanelli A.P., Roselino A.M., Cavassani K.A., Pereira M.S., Mortara R.A., Brodskyn C.I., et al. CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis 193 9 (May 1 2006) 1313-1322
28. Antonelli L.R., Dutra W.O., Oliveira R.R., Torres K.C., Guimaraes L.H., Bacellar O., et al. Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alphabeta and gammadelta T cells from human patients with cutaneous leishmaniasis. Infect Immun 74 11 (Nov 2006) 6317-6323
29. Thomson C.W., Lee B.P., and Zhang L. Double-negative regulatory T cells: non-conventional regulators. Immunol Res 35 1-2 (2006) 163-178
30. Fischer K., Voelkl S., Heymann J., Przybylski G.K., Mondal K., Laumer M., et al. Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells. Blood 105 7 (Apr 1 2005) 2828-2835
31. Sieling P.A., Porcelli S.A., Duong B.T., Spada F., Bloom B.R., Diamond B., et al. Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c. J Immunol 165 9 (Nov 1 2000) 5338-5344
32. Liu M.F., Yang C.Y., Chao S.C., Li J.S., Weng T.H., and Lei H.Y. Distribution of double-negative (CD4- CD8-, DN) T subsets in blood and synovial fluid from patients with rheumatoid arthritis. Clin Rheumatol 18 3 (1999) 227-231
33. Liu M.F., Li J.S., Weng T.H., and Lei H.Y. Double-negative (CD4-CD8-) TCRalphabeta+ cells in patients with systemic lupus erythematosus. Scand J Rheumatol 27 2 (1998) 130-134
34. Godfrey D.I., Hammond K.J., Poulton L.D., Smyth M.J., and Baxter A.G. NKT cells: facts, functions and fallacies. Immunol Today 21 11 (Nov 2000) 573-583
35. Taniguchi M., Seino K., and Nakayama T. The NKT cell system: bridging innate and acquired immunity. Nat Immunol 4 12 (Dec 2003) 1164-1165
36. Godfrey D.I., and Berzins S.P. Control points in NKT-cell development. Nat Rev 7 7 (Jul 2007) 505-518
37. Van Kaer L. NKT cells: T lymphocytes with innate effector functions. Curr Opin Immunol 19 3 (Jun 2007) 354-364
38. Amprey J.L., Im J.S., Turco S.J., Murray H.W., Illarionov P.A., Besra G.S., et al. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J Exp Med 200 7 (Oct 4 2004) 895-904
39. Derrick S.C., Evering T.H., Sambandamurthy V.K., Jalapathy K.V., Hsu T., Chen B., et al. Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccine. Immunology 120 2 (Feb 2007) 192-206
40. Alaibac M., Harms G., Zwingenberger K., Morris J., Yu R., and Chu A.C. Gamma delta T lymphocytes in oriental cutaneous leishmaniasis: occurrence and variable delta gene expression. Br J Dermatol 128 4 (Apr 1993) 388-392
41. Raziuddin S., Telmasani A.W., el-Hag el-Awad M., al-Amari O., and al-Janadi M. Gamma delta T cells and the immune response in visceral leishmaniasis. Eur J Immunol 22 5 (May 1992) 1143-1148
42. Russo D.M., Armitage R.J., Barral-Netto M., Barral A., Grabstein K.H., and Reed S.G. Antigen-reactive gamma delta T cells in human leishmaniasis. J Immunol 151 7 (Oct 1 1993) 3712-3718